Acurx Announces Scientific Oral and Poster Presented at IDWeek 2022
- Wednesday, October 26, 2022, 7:10
- PR Newswire
- Add a comment
Presents research on ibezapolstat’s selective activity on healthy bacteria within the gut microbiome in the treatment of C. difficile Infection (CDI) Emerging ibezapolstat microbiome data demonstrate that favorable effects seen in the Ph1 healthy volunteer study are also observed in the…
About the Author
admin has written 20652 stories on this site.